A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Slade’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
Plans whose provider directory lists this clinician
Licensed to practise in California · since 2000 · expires 2028-03-31 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$1,405 in 2024
Medicaid paid $1,405 for 101 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
Largest Medicaid services in 2024
Short return visit (20+ min)
29
$1,405
TOBACCO NON-USER
72
$0
Medicaid work by year
2024
101
2
18
$1,405
2023
43
2
17
$0
2022
26
1
14
$0
See the largest Medicaid services in earlier years
2023
Largest Medicaid services in 2023
TOBACCO NON-USER
17
$0
Short return visit (20+ min)
26
$0
2022
Largest Medicaid services in 2022
Short return visit (20+ min)
26
$0
Drugs they prescribed that Part D paid
$24,004
Pharmacies billed $24,004 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 230) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
205 generic and 25 brand-name prescriptions · $24,004 in drug cost · 25 antibiotic prescriptions to 23 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Largest Part D drug costs
Estring
16
$9,771
$611
Yuvafem
33
$3,592
$109
Estradiol
53
$1,938
$37
Oxybutynin Chloride Er
19
$379
$20
Clobetasol Propionate
12
$199
$17
See all 6 drugs
Every Part D drug this clinician prescribed
Estring
16
$9,771
$611
Yuvafem
33
$3,592
$109
Estradiol
53
$1,938
$37
Oxybutynin Chloride Er
19
$379
$20
Clobetasol Propionate
12
$199
$17
Sulfamethoxazole-Trimethoprim
12
$69
$6
Year by year
Part D prescribing by year
2024
230
142
0% (0)
11%
$24,004
2023
248
136
0% (0)
—None
$21,812
2022
181
115
—None
—None
$18,770
2021
127
66
0% (0)
13%
$9,674
2020
86
44
—None
19%
$9,279
2019
79
38
0% (0)
20%
$5,874
2018
68
33
—None
19%
$5,964
2017
87
36
—None
21%
$11,262
2016
82
33
0% (0)
32%
$10,843
2015
82
38
—None
34%
$10,487
2014
77
36
—None
35%
$6,847
2013
91
41
—None
30%
$8,479
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
Part D drugs prescribed in 2023
Estring
15
$8,916
$594
Yuvafem
26
$3,310
$127
Estradiol
66
$2,481
$38
Oxybutynin Chloride Er
29
$489
$17
Clobetasol Propionate
15
$261
$17
Medroxyprogesterone Acetate
12
$223
$19
Triamcinolone Acetonide
13
$209
$16
Fluconazole
13
$84
$6
2022: 3 drugs
Part D drugs prescribed in 2022
Estring
17
$9,622
$566
Estradiol
50
$2,066
$41
Oxybutynin Chloride Er
12
$365
$30
2021: 2 drugs
Part D drugs prescribed in 2021
Estradiol
42
$1,773
$42
Oxybutynin Chloride Er
16
$1,211
$76
2020: 2 drugs
Part D drugs prescribed in 2020
Estradiol
21
$896
$43
Oxybutynin Chloride Er
12
$457
$38
2019: 1 drug
Part D drugs prescribed in 2019
Estradiol
26
$847
$33
2018: 1 drug
Part D drugs prescribed in 2018
Estrace
11
$1,342
$122
2017: 2 drugs
Part D drugs prescribed in 2017
Estrace
18
$5,468
$304
Estradiol
11
$299
$27
2016: 2 drugs
Part D drugs prescribed in 2016
Oxybutynin Chloride Er
14
$1,985
$142
Estradiol
13
$531
$41
2015: 1 drug
Part D drugs prescribed in 2015
Estradiol
13
$409
$31
2013: 1 drug
Part D drugs prescribed in 2013
Estradiol
12
$197
$16
Money from drug and device companies
$125 in 2024
Industry payments by year
2024
1
1
—None
$125
2023
1
1
—None
$125
2019
2
2
—None
$223
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.